🎥 New video: Why dose optimisation matters for older people with advanced breast cancer.
The IMPORTANT project is studying CDK4/6 inhibitor dosing strategies to improve tolerability, quality of life, and shared decision-making in treatment.
#IMPORTANTproject #BreastCancer #HorizonEurope
The #IMPORTANTProject will join the #EUnetCCC Symposium on Cancer Treatment De-escalation
📅 5–6 March 2026
📍 NKI, Amsterdam
Proud to contribute to the discussion on personalised dose optimisation for older patients with advanced HR+/HER2- breast cancer
#DeEscalation #HorizonEurope #EUCancerMission
🎯Optimising treatment for older patients with metastatic #BreastCancer
Watch here: lnkd.in/dGzPDhBv
🔬The #IMPORTANTProject aims to optimise CDK4/6 inhibitor dosing through a multinational clinical trial integrating geriatric assessment–based strategies
🎗️Older patients deserve evidence-based care
The #IMPORTANTproject joined the 2nd #HorizonEurope Cancer Mission “Diagnosis & Treatment” Cluster Meeting in Berlin 🇩🇪
We shared actions on #CitizenEngagement & #AddressingInequalities in cancer care highlighting how we bring science closer to people.
#MissionCancer #CancerResearch #HaDEA
